Bill Revising ASP Calculation Surfaces Again In House; Medicare Cost Question Remains
This article was originally published in The Pink Sheet Daily
Bipartisan bill from Reps. Whitfield and Green would permanently exclude prompt pay discounts from the calculation of average sales price for drugs used in Medicare Part B.
You may also be interested in...
Cutting the payment level for Medicare Part B drugs is a perennial budget proposal, but never gets very far in Congress. Now, thanks to the sequester, Part B payments have been cut from ASP+6% to ASP+4.3%. Will it stick?
A 2% cut is being applied first to the average sales price for drugs reimbursed by Medicare Part B, and then another 2% is taken out of the 6% add-on. The approach compounds the overall reduction to a level that far exceeds the 2% Medicare cut required by sequestration, according to the groups.
Drug wholesalers and physicians could get their wish of having the average sales price calculation for Medicare Part B drugs exclude customary prompt pay discounts, under a provision added to the House Energy and Commerce Committee's portion of health care reform legislation. But the fix, if kept in, would only last five years